ESOPHAGEAL SQUAMOUS CELL CANCER
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: experimental drug targets advanced tumors
Disease control ENROLLING_BY_INVITATIONThis early-stage study is testing a new drug called RNDO-564, both by itself and combined with an existing immunotherapy (pembrolizumab), in adults with advanced cancers that have stopped responding to standard treatments. The main goals are to find safe doses and see how the bod…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Rondo Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New Two-Pronged attack on tough cancers shows promise
Disease control OngoingThis study is testing whether adding an experimental drug called futibatinib to standard immunotherapy and chemotherapy can better control advanced esophageal or pancreatic cancer. It is for adults who have not yet received treatment for their advanced disease. The main goal is t…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC